07:04:22 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande


Redsense Medical är specialiserade inom utvecklingen av blodläckagealarm. Bolagets produkt fungerar som en sensor baserad på fiberteknik som snabbare skall upptäcka blodförlust, samt larma och rapportera till olika larmenheter. Utöver huvudverksamheten erbjuds träning och utbildning inom affärsområdet. Bolaget etablerades under 2006 och har sitt huvudkontor i Halmstad.


2022-02-22 Bokslutskommuniké 2021
2021-11-09 Kvartalsrapport 2021-Q3
2021-08-24 Kvartalsrapport 2021-Q2
2021-05-12 Årsstämma 2021
2021-05-05 Ordinarie utdelning REDS 0.00 SEK
2021-05-03 Kvartalsrapport 2021-Q1
2021-04-19 Extra Bolagsstämma 2021
2021-02-22 Bokslutskommuniké 2020
2020-12-18 Extra Bolagsstämma 2020
2020-11-09 Kvartalsrapport 2020-Q3
2020-08-24 Kvartalsrapport 2020-Q2
2020-06-23 Ordinarie utdelning REDS 0.00 SEK
2020-06-22 Årsstämma 2020
2020-05-04 Kvartalsrapport 2020-Q1
2020-02-25 Bokslutskommuniké 2019
2019-11-18 Kvartalsrapport 2019-Q3
2019-08-26 Kvartalsrapport 2019-Q2
2019-05-07 Ordinarie utdelning REDS 0.00 SEK
2019-05-06 Årsstämma 2019
2019-05-06 Kvartalsrapport 2019-Q1
2019-02-26 Bokslutskommuniké 2018
2018-11-20 Kvartalsrapport 2018-Q3
2018-08-27 Kvartalsrapport 2018-Q2
2018-05-08 Ordinarie utdelning REDS 0.00 SEK
2018-05-07 Årsstämma 2018
2018-05-07 Kvartalsrapport 2018-Q1
2018-02-27 Bokslutskommuniké 2017
2017-11-22 Kvartalsrapport 2017-Q3
2017-09-25 Extra Bolagsstämma 2017
2017-08-28 Kvartalsrapport 2017-Q2
2017-05-10 Kvartalsrapport 2017-Q1
2017-04-06 Ordinarie utdelning REDS 0.00 SEK
2017-04-05 Årsstämma 2017
2017-02-22 Bokslutskommuniké 2016
2016-10-26 Kvartalsrapport 2016-Q3
2016-08-25 Kvartalsrapport 2016-Q2
2016-05-09 Kvartalsrapport 2016-Q1
2016-05-09 Årsstämma 2016
2016-02-23 Ordinarie utdelning REDS 0.00 SEK
2016-02-22 Bokslutskommuniké 2015
2015-11-27 Kvartalsrapport 2015-Q3
2020-09-21 10:00:00

Redsense Medical announces that the company's blood leakage alarm now is in use at all of the five largest dialysis care providers in the U.S. The alarm is also used at three of the top five hospitals in nephrology.

The five largest dialysis care providers - Fresenius, DaVita, U.S. Renal Care, American Renal Associates and Dialysis Clinic Inc. - have a combined patient base of close to 500,000 patients, about 8,000 of which receiving home hemodialysis, according to the Nephrology News & Issues survey. All of these providers are now using the Redsense Alarm as a precautionary measure to prevent haemorrhage due to Venous Needle Dislodgement.

The five highest-scoring hospitals for nephrology according to the U.S. News's evaluation are the Mayo Clinic in Rochester, MN, the New York-Presbyterian Hospital-Columbia and Cornell in New York, NY, the UCLA Medical Center in Los Angeles, CA, the Johns Hopkins Hospital in Baltimore, MD, and the Cleveland Clinic in Cleveland, OH. Out of these five, Mayo Clinic, Cleveland Clinic and New York Presbyterian all include Redsense in their clinical practice.

"We are seeing that Redsense's solution is becoming the established standard practice for major hemodialysis providers. This is true in particular in conjunction with at-home treatments, a modality that is undergoing strong growth in the U.S. market," says Redsense Medical's CEO Patrik Byhmer, and continues: "We are happy that our product continues to make an impact; providers and clinics are adopting it because it offers an efficient way to enhance patient safety and protect against one of the dangerous complications of hemodialysis."

Nephrology News & Issues' compilation of the largest dialysis care providers in the USA:

U.S. News and World Reports ranking of the best hospitals in nephrology:

About the Redsense Alarm

The Redsense Alarm is a medical device that uses proprietary, optical fibre technology to monitor the access sites for blood leakage during hemodialysis and trigger an alarm when blood is detected.